Reflecting on International Anti-Corruption Day, I recall my first visit to Bosnia and Herzegovina years ago. A visitor is always struck by the country’s beauty and diversity, the warmth of its people and the richness of its culture. Unfortunately, when …
Email adoption continues to see strong growth worldwide PALO ALTO, CA, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Contact: The Radicati Group, Inc. admin@radicati.com The Radicati Group, Inc.’s latest study, “Email Market, 2024- …
Gabe Jaksich’s 6 Month 1000 Hour Condensed Tattoo Apprenticeship Program Blends A Modern Approach With Old School Ethics MIAMI, FL, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Ink Different Tattoo School is proud to announce the launch …
MONTREAL, QUEBEC, CANADA, December 9, 2024 /EINPresswire.com/ -- Longbow Advantage, the innovative warehouse technology leader behind the Rebus platform, proudly announces that Longbow Advantage has been recognized as a Sample Vendor in the 2024 Gartner …
Como tecnologias avançadas, design integrado e automação redefinem os padrões de proteção e conforto em residências de alto luxo RIO DE JANEIRO, RIO DE JANEIRO, BRAZIL, December 9, 2024 /EINPresswire.com/ -- Com o aumento da preocupação com a segurança …
Empowering business leaders with actionable strategies, this workshop will offer stress management insights for peak performance. BOWIE, MD, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Empowering Business Owners to Tackle Stress and Thrive …
DURHAM, NC, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Hudson Therapeutics, the US subsidiary of Shaperon, a leading innovator in therapeutic solutions, is excited to announce its participation in three major bio industry events during …
PRESS RELEASE EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC, a clinical-stage biotech company pioneering the design and development of first-in- …
Rockville, MD, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Treatment for renal anemia, a chronic condition also known as anemia of chronic kidney disease, primarily focuses on enhancing red blood cell production. Popular medications such as epoetin are extensively …
Data demonstrate dose dependent survival advantage with AUTX-703 in primary patient-derived orthotopic AML model IND submissions on track for late 2024 NEWTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on …
BURLINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced it …
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE) celebrated the contributions of the companies and the leaders of BASF Corporation and Celanese Corporation, and lauded the good works of chemical engineers, at …
NORWOOD, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, today announced the dosing of the first patient in the Phase …
Brooklyn, NY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, today announced it has been awarded two project contracts totaling $6.7 million through its Advanced …
DES PLAINES, Ill., Dec. 09, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leading independent bus and coach manufacturer and a leader in zero-emission electric mass mobility solutions, subsidiary Motor Coach Industries …
Montreal, Canada, Dec. 09, 2024 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE December 9, 2024 Following the US elections there has been a good deal of talk about what the outcome will mean for relations between Canada and the United States. Issues around …
– Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 – – 100% of 1L NPM1-m and 96% of 1L KMT2A-r AML patients alive as of data cutoff with median follow-up of 31 and 19 …
WASHINGTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Dr. Henry Mahncke, CEO of Posit Science, the maker of the brain health and fitness app BrainHQ, will address the 6th Annual What’s Next Innovation Summit at the National Press Club in Washington DC and will …
Phase 1 clinical trial for OP-3136 to initiate in early 2025 SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, …
MIAMI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that the first patient has been enrolled in the company’s CGUARDIANS II …
